BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11391530)

  • 21. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
    Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
    Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple chromosomal abnormalities in human liver (pre)neoplasia.
    Raidl M; Pirker C; Schulte-Hermann R; Aubele M; Kandioler-Eckersberger D; Wrba F; Micksche M; Berger W; Grasl-Kraupp B
    J Hepatol; 2004 Apr; 40(4):660-8. PubMed ID: 15030983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity in precancerous hepatic nodules.
    Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; Papadimitriou CS
    Cancer; 1998 May; 82(10):1831-8. PubMed ID: 9587114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
    Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
    Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
    Zhao X; Wan D; Jiang H
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
    Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
    Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver.
    Aihara T; Noguchi S; Miyoshi Y; Nakano H; Sasaki Y; Nakamura Y; Monden M; Imaoka S
    Hepatology; 1998 Jul; 28(1):86-9. PubMed ID: 9657100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular immunohistochemical markers: contributions to hepatocellular nodule diagnosis in explanted livers.
    Nascimento C; Caroli-Bottino A; Paschoal J; Pannain VL
    Transplant Proc; 2009 Dec; 41(10):4211-3. PubMed ID: 20005371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
    Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
    Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error.
    Kawai H; Suda T; Aoyagi Y; Isokawa O; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Tsukada K; Mori S; Shimizu T; Suzuki Y; Abe Y; Takahashi T; Nomoto M; Asakura H
    Hepatology; 2000 Jun; 31(6):1246-50. PubMed ID: 10827149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    Li RK; Palmer SL; Zeng MS; Qiang JW; Chen F; Rao SX; Chen LL; Dai YM
    PLoS One; 2015; 10(11):e0142882. PubMed ID: 26605946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.